“Comparison of Efficacy and Safety of Vildagliptin and Linagliptin in Patients of Type 2 Diabetes Mellitus with Chronic Kidney Disease”, Comm. Based Med J, vol. 14, no. 1, pp. 96–100, Jan. 2025, doi: 10.3329/cbmj.v14i1.79340.